tradingkey.logo

Enhabit Inc

EHAB
8.310USD
+0.180+2.21%
Close 11/03, 16:00ETQuotes delayed by 15 min
420.49MMarket Cap
LossP/E TTM

Enhabit Inc

8.310
+0.180+2.21%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Enhabit Inc

Currency: USD Updated: 2025-11-03

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Enhabit Inc's Score

Industry at a Glance

Industry Ranking
27 / 78
Overall Ranking
144 / 4617
Industry
Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 5 analysts
Hold
Current Rating
9.375
Target Price
+15.31%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Enhabit Inc Highlights

StrengthsRisks
Enhabit, Inc. is a provider of home health and hospice services. The Company’s segments include Home Health and Hospice. The Home Health segment provides a range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. Its home health business benefits from a diversity of referral sources, with patients referred from acute care hospitals, inpatient rehabilitation facilities, surgery centers, assisted living facilities, and skilled nursing facilities, as well as community physicians. The Hospice segment provides hospice services for terminally ill patients and their families. Its Medicare-certified hospice operations provide hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and family member bereavement counseling. It operates over 110 hospice agencies and 255 home health agencies.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.03B.
Fairly Valued
The company’s latest PE is -3.13, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 52.80M shares, decreasing 15.35% quarter-over-quarter.
Held by Jana Partners
Star Investor Jana Partners holds 2.14M shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-03

The company's current financial score is 7.06, which is lower than the Healthcare Providers & Services industry's average of 7.24. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 266.10M, representing a year-over-year increase of 2.11%, while its net profit experienced a year-over-year increase of 2700.00%.

Score

Industry at a Glance

Previous score
7.06
Change
0

Financials

6.11

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

8.17

Operational Efficiency

7.17

Growth Potential

6.73

Shareholder Returns

7.12

Enhabit Inc's Company Valuation

Currency: USD Updated: 2025-11-03

The company’s current valuation score is 8.80, which is higher than the Healthcare Providers & Services industry's average of 7.09. Its current P/E ratio is -3.13, which is -31.63% below the recent high of -2.14 and -1810.19% above the recent low of -59.72.

Score

Industry at a Glance

Previous score
8.80
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 27/78
No Data

Earnings Forecast

Currency: USD Updated: 2025-11-03

The company’s current earnings forecast score is 6.80, which is lower than the Healthcare Providers & Services industry's average of 7.56. The average price target for Enhabit Inc is 9.00, with a high of 11.00 and a low of 8.50.

Score

Industry at a Glance

Previous score
6.80
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 5 analysts
Hold
Current Rating
9.375
Target Price
+15.31%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

64
Total
7
Median
9
Average
Company name
Ratings
Analysts
Enhabit Inc
EHAB
5
CVS Health Corp
CVS
30
HCA Healthcare Inc
HCA
27
Teladoc Health Inc
TDOC
26
Tenet Healthcare Corp
THC
24
Universal Health Services Inc
UHS
22
1
2
3
...
13

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-03

The company’s current price momentum score is 6.72, which is lower than the Healthcare Providers & Services industry's average of 6.93. Sideways: Currently, the stock price is trading between the resistance level at 8.85 and the support level at 7.74, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.81
Change
-0.09

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(5)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.047
Neutral
RSI(14)
52.083
Neutral
STOCH(KDJ)(9,3,3)
35.678
Neutral
ATR(14)
0.317
High Vlolatility
CCI(14)
-59.820
Neutral
Williams %R
54.545
Neutral
TRIX(12,20)
0.224
Sell
StochRSI(14)
42.921
Buy
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
8.330
Sell
MA10
8.444
Sell
MA20
8.244
Buy
MA50
8.083
Buy
MA100
7.934
Buy
MA200
8.383
Sell

Institutional Confidence

Currency: USD Updated: 2025-11-03

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Providers & Services industry's average of 6.96. The latest institutional shareholding proportion is 104.17%, representing a quarter-over-quarter increase of 0.47%. The largest institutional shareholder is The Vanguard, holding a total of 3.12M shares, representing 6.15% of shares outstanding, with 6.20% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Deerfield Management Company, L.P.
4.78M
-4.36%
8 knots Management LLC
3.85M
-22.76%
BlackRock Institutional Trust Company, N.A.
3.35M
-0.62%
UBS Financial Services, Inc.
3.34M
+10.07%
The Vanguard Group, Inc.
Star Investors
3.12M
+5.34%
AREX Capital Management, LP
2.48M
+0.20%
LOYS AG
2.34M
--
JANA Partners LLC
Star Investors
2.14M
--
Dimensional Fund Advisors, L.P.
2.04M
+0.84%
Systematic Financial Management, L.P.
1.94M
-3.51%
1
2

Risk Assessment

Currency: USD Updated: 2025-11-03

The company’s current risk assessment score is 5.85, which is higher than the Healthcare Providers & Services industry's average of 5.45. The company's beta value is 1.32. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
5.85
Change
0
Beta vs S&P 500 index
1.32
VaR
--
240-Day Maximum Drawdown
+39.63%
240-Day Volatility
+46.58%

Return

Best Daily Return
60 days
+5.42%
120 days
+15.21%
5 years
--
Worst Daily Return
60 days
-4.89%
120 days
-18.26%
5 years
--
Sharpe Ratio
60 days
+0.91
120 days
-0.78
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+39.63%
3 years
+59.30%
5 years
--
Return-to-Drawdown Ratio
240 days
+0.33
3 years
-0.21
5 years
--
Skewness
240 days
+0.76
3 years
-0.06
5 years
--

Volatility

Realised Volatility
240 days
+46.58%
5 years
--
Standardised True Range
240 days
+3.89%
5 years
--
Downside Risk-Adjusted Return
120 days
-92.96%
240 days
-92.96%
Maximum Daily Upside Volatility
60 days
+24.95%
Maximum Daily Downside Volatility
60 days
+22.38%

Liquidity

Average Turnover Rate
60 days
+1.27%
120 days
+1.00%
5 years
--
Turnover Deviation
20 days
-0.53%
60 days
+19.29%
120 days
-5.96%

Peer Comparison

Healthcare Providers & Services
Enhabit Inc
Enhabit Inc
EHAB
7.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Natera Inc
Natera Inc
NTRA
8.67 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ensign Group Inc
Ensign Group Inc
ENSG
8.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Pediatrix Medical Group Inc
Pediatrix Medical Group Inc
MD
8.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Encompass Health Corp
Encompass Health Corp
EHC
8.30 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Addus Homecare Corp
Addus Homecare Corp
ADUS
8.26 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI